- Aceclofenac 2 studies
- Adapalene 19 studies
- Arthrotec 1 study
- Balsalazide 7 studies
- Betulinic acid 1 study
- Bromfenac 15 studies
- Bucillamine 1 study
- Celecoxib 236 studies
- Chloroquine diphosphate 44 studies
- Choline magnesium trisalicylate 1 study
- CNI 1493 4 studies
- Diclofenac hydroxyethylpyrrolidine 2 studies
- Efamol 3 studies
- Etoricoxib 31 studies
- Icatibant 5 studies
- Indobufen 1 study
- Lisofylline 1 study
- Lornoxicam 2 studies
- Loxoprofen 2 studies
- Meloxicam 18 studies
- Nitroaspirin 2 studies
- Olopatadine 9 studies
- Olsalazine 1 study
- Parecoxib 11 studies
- Parthenolide 2 studies
- Pimecrolimus 45 studies
- Pirfenidone 13 studies
- Prexige 16 studies
- Resveratrol 9 studies
- Rofecoxib 29 studies
- Salicylsalicylic acid 612 studies
- Samarium ethylenediaminetetramethylenephosphonate 12 studies
- Suberoylanilide hydroxamic acid 91 studies
- Sulindac sulfone 12 studies
- TNFR-Fc fusion protein 166 studies
- Tranilast 3 studies
- Valdecoxib 25 studies
- Ziconotide 3 studies
- Zileuton 11 studies
- 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid 1 study
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
